German healthcare and materials group Merck KGaA has dropped a surcharge on life sciences sector orders within China ...

SHANGHAI (Reuters) -German healthcare and materials group Merck KGaA has dropped a surcharge on life sciences sector orders within China following the U.S.-China agreement to pause sky-high tariffs on ...

As has been the case for several quarters now, Merck KGaA’s life science business continues to serve as a weathervane for the ...

FRANKFURT: German pharmaceutical and specialty materials group Merck KGaA on Thursday guided more cautiously for 2025 ...

Novo Nordisk announced it will work with the biotech Septerna to develop oral GLP-1 obesity drugs in a deal worth up to $2.2 ...

Dear ladies and gentlemen, welcome to the Merck Investor and Analyst Conference ... this week’s trade agreement between the U.S. and China is restricted to 90 days and no more.

The preemptive warnings from these and other blue chips may vastly underestimate the overall hit to bottom lines.